Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.10p
   
  • Change Today:
      0.20p
  • 52 Week High: 10.60
  • 52 Week Low: 4.10
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 1,055,562
  • Market Cap: £45.50m

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.0  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Poolbeg Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (2.34) (0.74)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Poolbeg Pharma Company Announcements

Strategic expansion of POLB 001 into oncology 16-Jan-2023 07:00 RNS
Second Price Monitoring Extn 09-Jan-2023 09:05 RNS
Price Monitoring Extension 09-Jan-2023 09:00 RNS

Poolbeg Pharma ShareCast News

Poolbeg expands its focus molecule into oncology 16-Jan-2023 ShareCast
Poolbeg identifies new drug candidates with OneT... 21-Dec-2022 ShareCast
Poolbeg secures exclusive licence to possible ob... 14-Dec-2022 ShareCast

Latest Poolbeg Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 9.10p
Change Today 0.20p
% Change 2.25 %
52 Week High 10.60
52 Week Low 4.10
Volume 1,055,562
Shares Issued 500.00m
Market Cap £45.50m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.43% below the market average30.43% below the market average30.43% below the market average30.43% below the market average30.43% below the market average
12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average
Price Trend
81.63% above the market average81.63% above the market average81.63% above the market average81.63% above the market average81.63% above the market average
86.89% above the sector average86.89% above the sector average86.89% above the sector average86.89% above the sector average86.89% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 27-Jan-2023

Time Volume / Share Price
17:07 30,000 @ 9.10p
16:24 8,658 @ 9.24p
16:22 14,000 @ 9.15p
16:20 15,000 @ 8.96p
16:17 300,000 @ 9.00p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page